- YSB published an annual results announcement for the year ended Dec. 31, 2025.
- Revenue rose 17.1% to RMB20.97 billion, while gross profit increased 27.2% to RMB2.31 billion.
- Profit attributable to owners was RMB152.97 million and basic earnings per share were RMB0.224.
- Adjusted net profit increased 51.2% to RMB237.06 million, and the company recommended a final dividend of RMB0.110 per share.
- Management said the revenue increase was driven mainly by continued development of the self-operation business and contributions from an acquisition, while online marketplace revenue fell 1.7% to RMB866.03 million due to a downturn in the pharmaceutical retail market affecting third-party sellers.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. YSB Inc. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260323-12062700), on March 23, 2026, and is solely responsible for the information contained therein.
Comments